Literature DB >> 29273110

Cytokine Targeted Therapeutics for Alopecia Areata: Lessons from Atopic Dermatitis and Other Inflammatory Skin Diseases.

Kunal Malik1, Emma Guttman-Yassky2.   

Abstract

Alopecia areata is a T-cell-mediated disease that shares phenotypic similarities with other inflammatory diseases, particularly atopic dermatitis, and lacks safe, effective, mechanism-specific treatments. Increasing data suggests that alopecia areata harbors contributions of T helper type 1, T helper type 2, T helper type 17/IL-23, and phosphodiesterase pathways. Antagonism of these axes is undergoing evaluation, and might elucidate the underlying molecular circuitry of alopecia areata, advancing the translational revolution for this disease.
Copyright © 2017 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29273110     DOI: 10.1016/j.jisp.2017.10.005

Source DB:  PubMed          Journal:  J Investig Dermatol Symp Proc        ISSN: 1087-0024


  3 in total

1.  IL12B and IL23R polymorphisms are associated with alopecia areata.

Authors:  Pardis-Sadat Tabatabaei-Panah; Hamideh Moravvej; Sara Delpasand; Mona Jafari; Sanaz Sepehri; Reyhaneh Abgoon; Ralf J Ludwig; Reza Akbarzadeh
Journal:  Genes Immun       Date:  2020-05-01       Impact factor: 2.676

2.  A phase 2a randomized vehicle-controlled multi-center study of the safety and efficacy of delgocitinib in subjects with moderate-to-severe alopecia areata.

Authors:  Daniela Mikhaylov; Jacob W Glickman; Ester Del Duca; John Nia; Peter Hashim; Giselle K Singer; Alba L Posligua; Aleksandra G Florek; Erin Ibler; Erika L Hagstrom; Yeriel Estrada; Stephanie M Rangel; Maria Colavincenzo; Amy S Paller; Emma Guttman-Yassky
Journal:  Arch Dermatol Res       Date:  2022-03-01       Impact factor: 3.017

Review 3.  The Role of Serum Th1, Th2, and Th17 Cytokines in Patients with Alopecia Areata: Clinical Implications.

Authors:  Anna Waśkiel-Burnat; Marta Osińska; Anna Salińska; Leszek Blicharz; Mohamad Goldust; Małgorzata Olszewska; Lidia Rudnicka
Journal:  Cells       Date:  2021-12-02       Impact factor: 6.600

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.